Breast Cancer
-
Navelbine(Vinorelbine) – NSCLC | HongKong DengYue Medicine
-
ENHERTU (Trastuzumab Deruxtecan) – HER2-driven cancers | HongKong DengYue Medicine
-
Herceptin (Trastuzumab) – Breast Cancer | HongKong DengYue Medicine
-
Kisqali (Ribociclib) – Breast Cancer | HongKong DengYue Medicine
-
Truqap (Capivasertib) – Breast Cancer | HongKong DengYue Medicine
-
Lynparza (Olaparib) – Ovarian Cancer | HongKong DengYue Medicine
-
Airuikang (Dalpiciclib Isethionate) | Breast Cancer
-
Utidelone Injection | Breast Cancer | HongKong DengYue Medicine
-
Cipterbin (Inetetamab) | Metastatic Breast Cancer | DengYue
-
Kadcyla (Trastuzumab Emtansine) | Metastatic Breast Cancer | DengYue
-
Perjeta (Pertuzumab) | Metastatic Breast Cancer | HongKong DengYue
-
Irene (Pyrotinib) | Breast Cancer | HongKong DengYue Medicine
-
Ibrance (Palbociclib) | Breast Cancer | HongKong DengYue
-
Datopotamab Deruxtecan-dlnk | Breast Cancer | HongKong DengYue Medicine
-
Inavolisib | Metastatic Breast Cancer | HongKong DengYue Medicine
-
Talzenna (Talazoparib)｜Breast Cancer｜HongKong DengYue Medicine
Copyright@ 2016-2024 Hong Kong Deng Yue Med Al Rights